Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2005

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/Ritonavir

DRUG

Abacavir sulfate

DRUG

Nevirapine

DRUG

Lamivudine

DRUG

Stavudine

Trial Locations (23)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10029

Mount Sinai Med Ctr, New York

14642

Univ of Rochester Medical Center, Rochester

21287

Johns Hopkins Hosp, Baltimore

27710

Duke Univ Med Ctr, Durham

44106

Case Western Reserve Univ, Cleveland

46202

Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis

Methodist Hosp of Indiana / Life Care Clinic, Indianapolis

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

80262

Denver Dept of Health and Hosps, Denver

Univ of Colorado Health Sciences Ctr, Denver

96816

Univ of Hawaii, Honolulu

275997215

Univ of North Carolina, Chapel Hill

441091998

MetroHealth Med Ctr, Cleveland

452670405

Univ of Cincinnati, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

775550435

Univ of Texas Galveston, Galveston

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

02215

Beth Israel Deaconess - West Campus, Boston

02906

Miriam Hosp / Brown Univ, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00004855 - Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs | Biotech Hunter | Biotech Hunter